4//SEC Filing
McMahon Robert W. 4
Accession 0000105770-25-000074
CIK 0000105770other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:19 PM ET
Size
14.7 KB
Accession
0000105770-25-000074
Insider Transaction Report
Form 4
McMahon Robert W.
SVP & Chief Financial Officer
Transactions
- Award
Rst. Stock Unit
2025-08-11+12,670→ 12,670 totalExercise: $0.00→ Common Stock (12,670 underlying) - Award
Stock Option (Right to Buy)
2025-08-11$240.33/sh+7,647$1,837,804→ 7,647 totalExercise: $240.33From: 2026-08-11Exp: 2035-08-11→ Common Stock (7,647 underlying) - Award
Stock Option (Right to Buy)
2025-08-11$240.33/sh+7,137$1,715,235→ 7,137 totalExercise: $240.33From: 2026-08-11Exp: 2035-08-11→ Common Stock (7,137 underlying) - Award
Rst. Stock Unit
2025-08-11+3,168→ 3,168 totalExercise: $0.00→ Common Stock (3,168 underlying)
Footnotes (2)
- [F1]This award vests in three installments. 4,223 shares will vest six months from the grant date, 6,335 shares will vest 12 months from the grant date, and 2,112 shares will vest 24 months from the grant date.
- [F2]This award vests in four equal installments beginning on August 11, 2026.
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001608730
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 7:19 PM ET
- Size
- 14.7 KB